AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၉.၆၈ US$
arrow_downward
-၀.၇၀%(-၀.၂၁) 1D
၂၉.၆၈ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၁၈, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၂၉.၅၇ US$
High
၃၀.၄၈ US$
Low
၂၉.၂၂ US$
Mkt. cap
၁၇၇.၅၁ ဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၀.၀၀
52-wk high
၄၄.၀၇ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၉.၅၇ US$
High
၃၀.၄၈ US$
Low
၂၉.၂၂ US$
Mkt. cap
၁၇၇.၅၁ ဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၀.၀၀
52-wk high
၄၄.၀၇ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
BigGo Finance
·
ပြီးခဲ့သည့် ၄ နာရီ
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
ပြီးခဲ့သည့် ၃ နာရီ
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
TradingView
·
ပြီးခဲ့သည့် ၂ နာရီ
Stock Market: Will S&P 500 Open Up or Down Today?
Traders Union
·
ပြီးခဲ့သည့် ၆ နာရီ
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc